Comments
Shares of Glenmark Pharmaceuticals Ltd fall as much as 7.24% to Rs 385.5, their lowest since August 3, 2012
The pharma major posts a 53% drop in June quarter profit to Rs 109 crore ($15.37 mln) against Rs 233 crore in the corresponding quarter last year, impacted due to moderate performance in the US and subdued performance in Latin America
Total expenses had risen 9.5% to Rs 1,977 crore
The first quarter profit misses estimates of Rs 182 crore.
Up to last close, Glenmark has lost 40% this year, while Sun Pharmaceutical, which posted a 31% jump in Q1 profit on Tuesday, is up 2%
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.